Duopharma Biotech Bhd (DUOP)

Currency in MYR
1.340
-0.030(-2.19%)
Closed·
DUOP Scorecard
Full Analysis
Trading at a low P/E ratio relative to near-term earnings growth
DUOP is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1.3401.360
52 wk Range
1.0701.460
Key Statistics
Bid/Ask
1.33 / 1.35
Prev. Close
1.37
Open
1.36
Day's Range
1.34-1.36
52 wk Range
1.07-1.46
Volume
361.9K
Average Volume (3m)
793.5K
1-Year Change
11.57%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
DUOP Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
1.678
Upside
+25.22%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a low earnings multiple

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Duopharma Biotech Bhd Company Profile

Duopharma Biotech Berhad, an investment holding company, researches, develops, manufactures, distributes, and imports pharmaceutical products and medicines in Malaysia and internationally. The company offers consumer healthcare products, such as vitamins, minerals, and supplements, analgesics, eyecare, antacids, and skin care products; and generic drugs for various therapeutic classes, such as cardiovascular, dermatology, hormones, respiratory, sensory and nervous system, musculo-skeletal system, anti-infectives, and others. It also provides specialty pharmaceutical drugs for targeted conditions, biosimilar products, and medical devices and consumables to patients with conditions, including diabetes, cancer, cardiovascular, renal, and other diseases. The company’s product portfolio includes covasc, crystorvas, and vytocor; lebreta, and krabeva; and unihepa, erysaa, bi-haemosol, and haemosol. In addition, it offers its products under the Champs, Flavettes, Eye Glo, Proviton, Naturalle, IRORO Nutreatment, and Uphamol brands. The company was formerly known as CCM Duopharma Biotech Berhad and changed its name to Duopharma Biotech Berhad in February 2019. The company was founded in 1978 and is based in Klang, Malaysia.

Employees
1957
Market
Malaysia

Compare DUOP to Peers and Sector

Metrics to compare
DUOP
Peers
Sector
Relationship
P/E Ratio
17.7x22.4x−0.5x
PEG Ratio
0.30−0.710.00
Price/Book
1.8x1.9x2.6x
Price / LTM Sales
1.5x2.1x3.2x
Upside (Analyst Target)
24.1%13.9%41.2%
Fair Value Upside
Unlock13.6%6.2%Unlock

Analyst Ratings

5 Buy
0 Hold
0 Sell
Ratings:
5 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 1.678
(+25.22% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.08%
Dividend Yield
2.24%
Industry Median 4.16%
Annualised payout
0.03
Paid unevenly
5-Years Growth
-7.79%
Growth Streak

Earnings

Latest Release
May 15, 2025
EPS / Forecast
0.027 / --
Revenue / Forecast
262.70M / --
EPS Revisions
Last 90 days

DUOP Income Statement

People Also Watch

6.21
RHBC
-1.11%
9.52
MBBM
-0.21%
0.715
GTCY
-2.05%
1.120
YTLR
-0.88%

FAQ

What Stock Exchange Does Duopharma Biotech Trade On?

Duopharma Biotech is listed and trades on the Kuala Lumpur Stock Exchange stock exchange.

What Is the Stock Symbol for Duopharma Biotech?

The stock symbol for Duopharma Biotech is "DUOP."

What Is the Duopharma Biotech Market Cap?

As of today, Duopharma Biotech market cap is 1.30B.

What Is Duopharma Biotech's Earnings Per Share (TTM)?

The Duopharma Biotech EPS (TTM) is 0.08.

When Is the Next Duopharma Biotech Earnings Date?

Duopharma Biotech will release its next earnings report on 13 Aug 2025.

From a Technical Analysis Perspective, Is DUOP a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Duopharma Biotech Stock Split?

Duopharma Biotech has split 5 times.

How Many Employees Does Duopharma Biotech Have?

Duopharma Biotech has 1957 employees.

What is the current trading status of Duopharma Biotech (DUOP)?

As of 29 Jul 2025, Duopharma Biotech (DUOP) is trading at a price of 1.34, with a previous close of 1.37. The stock has fluctuated within a day range of 1.34 to 1.36, while its 52-week range spans from 1.07 to 1.46.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.